8-KLeadership ChangesRegulation FDExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Executive Changes (Jun 24, 2021)

Filed June 24, 2021For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has announced a change to its Board of Directors through a Form 8-K filing. Effective June 23, 2021, the Board has been expanded from nine to ten members with the appointment of David S. Wichmann. Mr. Wichmann will serve as a director until the next annual stockholders meeting. His appointment is part of a broader strategy to enhance board expertise and oversight. Mr. Wichmann's compensation as a non-employee director will be prorated from his appointment date until the 2022 annual meeting. This includes a cash retainer of approximately $99,500 and an equity award valued at approximately $177,400. The company has also stated its intention to enter into an indemnification agreement with Mr. Wichmann, consistent with existing agreements for other directors. The press release announcing this appointment was issued on June 24, 2021.

Key Highlights

  • 1Board expansion from nine to ten directors.
  • 2Appointment of David S. Wichmann as a new director, effective June 23, 2021.
  • 3Mr. Wichmann to serve as a director until the next annual meeting of stockholders.
  • 4Prorated director compensation for Mr. Wichmann: approximately $99,500 cash retainer and $177,400 in equity award.
  • 5Standard director indemnification agreement to be entered into with Mr. Wichmann.
  • 6No undisclosed arrangements or material interests in transactions for Mr. Wichmann's appointment.

Frequently Asked Questions

The filing does not provide specific details about David S. Wichmann's background or the exact reasons for his appointment, other than that it was made upon the recommendation of the Nominating and Governance Committee. It's common for companies to add directors with specific expertise to enhance board oversight and strategic guidance. Investors may need to refer to future filings or company communications for more detailed information on his qualifications.

Mr. Wichmann will receive standard non-employee director compensation, prorated for his term. This includes a cash retainer of approximately $99,500 and an equity award valued at approximately $177,400. The exact number of equity shares will be determined on July 1, 2021.

The 8-K filing focuses solely on the director appointment and associated compensation. While the addition of a new director can bring fresh perspectives, this filing itself does not provide direct evidence of a major strategic shift. Investors should monitor future company announcements and financial reports for insights into strategic changes.

The indemnification agreement is a standard practice designed to protect directors from personal liability for actions taken in their capacity as directors, provided they acted in good faith. It is consistent with agreements provided to other existing directors and is intended to attract and retain qualified individuals to serve on the board.